SEC Form 4 · accession 0001127602-17-031967
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James R Meyers
Officer — EVP Worldwide Commercial Ops
Period of report
Nov 9, 2017
Accepted (ET)
Nov 13, 2017 · 7:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2017 | A | 2,700 | $0.00 | A | 5,415 | D | |
| Common Stock | Nov 9, 2017 | F | 1,373 | $73.02 | D | 4,042 | D | |
| Common Stock | Nov 9, 2017 | G | 1,327 | $0.00 | D | 2,715 | D | |
| Common Stock | Nov 9, 2017 | G | 1,327 | $0.00 | A | 129,760 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issuance of common stock upon vesting of certain performance share awards on November 9, 2017.